Table of contents

  • Foreword
  • Assessment perspective
  • Definition  and scope of the topic
  • Rationale for office pathology  testing-and some questions
  • Assessment of product performance
  • Product performance under  'office conditions'
  • Use in the clinical setting
  • Clinical consequences of product  performance
  • Cost considerations
  • Political and organisational factors
  • Implications for new biotechnology-based products
  • Synthesis
  • References and bibliography
  • Appendix-1. Other settings for office pathology
  • Appendix 2. Slide material